Signos Weight Transformation Kit
Your metabolic transformation toolkit
24/7 Glucose Monitoring
A 15-day biosensor delivers round-the-clock glucose data straight to your app.2
AI that doesn’t BS
Get predictions, personalized nudges, and pattern-spotting for serious metabolic control.
REAL SUPPORT
Chat with a dietitian in-app or book a face-to-face1 for clear, personalized guidance.
PERSONALIZED AI insights
Stay ahead of spikes with movement alerts, guiding insights, and health reports.
Smart food logging
Snap a pic, scan a barcode, or type it in—Signos shows you how it affects your glucose.
Stress and sleep tracking
Spoiler: your metabolism doesn’t just care about food. Stress and sleep hit hard, too.
“I’ve tried diets, exercise, everything. This is the only thing that has helped me lose weight!”
-Kay C.
What customers are saying:
“I’ve tried diets, exercise, everything. This is the only thing that has helped me lose weight!”
-Kay C.
4.8
Product rating
86%
11%
2%
1%
0%
Tens of thousands of people have joined Signos to better understand their bodies. Members report steadier energy and a new sense of control over their health. It’s not just a tool; it’s a total shift in how people eat, move, and feel. Read more about their experiences.
Frequently asked questions
Your questions answered
Signos is a real-time metabolic health platform that combines an AI-powered app with a continuous glucose monitor (CGM). Your glucose data is sent directly to the app and combined with hundreds of millions of data points to predict responses to food and movement, track trends, log meals, track your weight, and access science-backed guidance to build sustainable, glucose-stable habits. You can also sync with Apple Health, Google Health Connect, smartwatches, and smart scales for a more complete view of your health.
Signos uses glucose data and millions of data points from logged meals, workouts, and other habits to deliver personalized guidance. When something you eat spikes your glucose, the app can suggest the right type and intensity of movement (based on your history) to help bring it back down. Over time, keeping your glucose more stable can lead to better energy, sharper focus, improved metabolic health, reduced risk of chronic conditions, and sustainable weight management.
Read more about how Signos works.
Yes, when used consistently, CGMs (also known as biosensors) can support healthy, sustainable weight management by helping you understand how your body responds to food, exercise, and daily habits in real time.
Research shows that 87% of CGM users change their food choices based on glucose feedback, and nearly half are more likely to move their bodies when they see a spike. Over 90% of users say CGMs help them lead a healthier lifestyle.
By showing you when your glucose rises or crashes, CGMs make it easier to recognize patterns, like cravings driven by glucose dips or energy crashes, and to respond with small, effective adjustments. This kind of insight can help you delay eating when your body still has fuel to burn, choose foods that support more stable glucose, and use short bursts of movement to bring high glucose levels back down.
Signos takes that a step further by using your personal glucose data, meal logs, and workout history to suggest what to eat next or how to move, so you’re not guessing. With consistent use, CGMs paired with in-the-moment guidance can help retrain your appetite, reduce overeating, and build habits that support long-term weight and fat loss.
For the latest information regarding the science behind glucose, insulin, fat storage, and weight loss, read The Scientific Evidence for Using CGMs for Weight Loss.
Possibly, but it depends on your HSA/FSA provider. Coverage varies, so check with your provider to confirm whether CGMs and wellness programs like Signos are eligible.
Please note: Signos is not responsible for reimbursement, and the cancellation policy and terms still apply, even if your provider does not approve coverage or reimbursement.
If weight loss is your goal, consider the amount of weight you’d like to lose and the recommended pace of 1 to 2 pounds per week. For example, a 25-pound weight loss goal is typically well supported by a 6-month plan. All plans give you full access to the Signos platform and behavior change program for the duration of your subscription.
All Signos plans include the Stelo glucose biosensor by Dexcom, and the app is designed to work exclusively with this device. You will receive six sensors with your order, with six-month subscriptions receiving another shipment three months later. Your CGM automatically takes a glucose reading every five minutes and sends the data to your phone every 15 minutes via Bluetooth.
As seen in:
In a world filled with noise, we give you the facts.
The trademarks Dexcom, Stelo, and any related logos and design marks are trademarks of Dexcom, Inc. and are used with permission. © 2025 Dexcom, Inc.
Apple, Apple Health, Apple Watch, and iPhone are trademarks of Apple Inc. Google, Google Health Connect, and Android are trademarks of Google LLC.
Don't miss out!
Sign up to be the first to know about special offers and exciting Signos news.
Signos indications: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.
The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
OPENLOOP CLINICAL AND PHARMACEUTICAL SERVICES:
Signos is a technology platform and wellness program provider. With the exception of registered dieticians, Signos does not employ licensed health care professionals to practice medicine, does not diagnose, treat, cure, or prevent any disease or medical condition, and does not provide medical advice. You should always consult your own health care professional for diagnosis, treatment, and care regarding any medical condition or health concern. Clinical services accessible through the Signos platform are provided solely by OpenLoop Health and other independent networks of U.S.-licensed clinicians, who exercise their own independent medical judgment to determine eligibility for GLP‑1 treatment based on medical history and assessment responses. These independent providers retain full discretion to prescribe or decline compounded GLP‑1 medications. Signos does not direct, control, or influence any clinical decision made by these providers, and no provider-patient relationship is created between you and Signos.
Compounded medications that may be made available in connection with the Signos program are produced in FDA-registered facilities, but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Signos does not manufacture, compound, dispense, or distribute any medications. Signos partners with certified U.S. pharmacies to help facilitate access to these medications, but Signos makes no representations or warranties regarding the safety, efficacy, suitability, or quality of any compounded medication. Product appearance may differ from website images.
Medication costs are included in the Signos program; however, inclusion of medication costs does not constitute the practice of medicine or pharmacy by Signos. Results may vary and depend on individual adherence, independent provider guidance, and lifestyle changes. Unless otherwise noted, results referenced reflect individual Signos patient experiences rather than public clinical studies, and no particular outcome is guaranteed.
Nothing on this website or within the Signos platform should be construed as medical advice, a medical diagnosis, or a recommendation for any specific treatment. If you are experiencing a medical emergency, call 911 or your local emergency services immediately.
